The method is a high-throughput, vector-free microfluidic platform for intracellular delivery of a wide range of materials; carbon nanotubes, proteins, and siRNA, into over 20 cell types, including embryonic stem cells and naïve immune cells.
The method is a high-throughput-free microfluidic platform for intracellular delivery of a wide range of materials; carbon nanotubes, proteins, and siRNA. This is into over 20 cell types. This is including embryonic stem cells. This is including naïve immune cells. Throughput is vector.